KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Cash from Investing Activities (2016 - 2025)

Sarepta Therapeutics has reported Cash from Investing Activities over the past 15 years, most recently at $96.2 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 87.41% year-over-year to $96.2 million; the TTM value through Dec 2025 reached $69.6 million, down 90.78%, while the annual FY2025 figure was $69.6 million, 90.78% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was $96.2 million at Sarepta Therapeutics, down from $232.4 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $764.1 million in Q4 2024 and troughed at -$785.8 million in Q1 2022.
  • A 5-year average of $5.4 million and a median of $15.8 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 1201.37% in 2023 and later soared 1651.49% in 2024.
  • Year by year, Cash from Investing Activities stood at -$2.6 million in 2021, then soared by 480.13% to $9.8 million in 2022, then crashed by 756.98% to -$64.4 million in 2023, then surged by 1287.29% to $764.1 million in 2024, then plummeted by 87.41% to $96.2 million in 2025.
  • Business Quant data shows Cash from Investing Activities for SRPT at $96.2 million in Q4 2025, $232.4 million in Q3 2025, and $32.2 million in Q2 2025.